Matches in Wikidata for { <http://www.wikidata.org/entity/Q65387285> ?p ?o ?g. }
Showing items 1 to 34 of
34
with 100 items per page.
- Q65387285 description "clinical trial" @default.
- Q65387285 description "ensayu clínicu" @default.
- Q65387285 description "klinisch onderzoek" @default.
- Q65387285 description "клінічне випробування" @default.
- Q65387285 description "կլինիկական փորձարկում" @default.
- Q65387285 name "PROTECT-2: A Study of the Selective A1 Adenosine Receptor Antagonist KW-3902 for Patients Hospitalized With Acute HF and Volume Overload to Assess Treatment Effect on Congestion and Renal Function" @default.
- Q65387285 name "PROTECT-2: A Study of the Selective A1 Adenosine Receptor Antagonist KW-3902 for Patients Hospitalized With Acute HF and Volume Overload to Assess Treatment Effect on Congestion and Renal Function" @default.
- Q65387285 type Item @default.
- Q65387285 label "PROTECT-2: A Study of the Selective A1 Adenosine Receptor Antagonist KW-3902 for Patients Hospitalized With Acute HF and Volume Overload to Assess Treatment Effect on Congestion and Renal Function" @default.
- Q65387285 label "PROTECT-2: A Study of the Selective A1 Adenosine Receptor Antagonist KW-3902 for Patients Hospitalized With Acute HF and Volume Overload to Assess Treatment Effect on Congestion and Renal Function" @default.
- Q65387285 prefLabel "PROTECT-2: A Study of the Selective A1 Adenosine Receptor Antagonist KW-3902 for Patients Hospitalized With Acute HF and Volume Overload to Assess Treatment Effect on Congestion and Renal Function" @default.
- Q65387285 prefLabel "PROTECT-2: A Study of the Selective A1 Adenosine Receptor Antagonist KW-3902 for Patients Hospitalized With Acute HF and Volume Overload to Assess Treatment Effect on Congestion and Renal Function" @default.
- Q65387285 P1050 Q65387285-F3FBE920-58AC-402B-93E6-8C258EC48AF1 @default.
- Q65387285 P1132 Q65387285-456D6834-0809-45D3-B23E-6E57D51127DC @default.
- Q65387285 P1476 Q65387285-F59DFEB7-5707-4FD7-B663-8EE9B5CEB9A3 @default.
- Q65387285 P2899 Q65387285-1BCA8304-E73B-46C9-8591-998D6DF2D319 @default.
- Q65387285 P3098 Q65387285-F303D323-D50B-43FA-9F47-86F603BC965A @default.
- Q65387285 P31 Q65387285-9BA1B0C6-5E17-452A-8EF0-5BC111DF9D84 @default.
- Q65387285 P4844 Q65387285-DE651E44-A732-458F-8EDC-11EA5DC011AA @default.
- Q65387285 P580 Q65387285-7363B517-3914-4BEF-A2EE-1547EE10E3A6 @default.
- Q65387285 P582 Q65387285-C7BE6E35-027A-4991-B06D-DDEDC4C81B38 @default.
- Q65387285 P6099 Q65387285-D515CBD8-0646-4C02-B22A-07625AF76A7E @default.
- Q65387285 P8363 Q65387285-795B4FEC-AA8B-48EA-89E4-AD819FD9B3B1 @default.
- Q65387285 P1050 Q181754 @default.
- Q65387285 P1132 "+1102" @default.
- Q65387285 P1476 "A Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Effects of KW-3902 Injectable Emulsion on Heart Failure Signs and Symptoms and Renal Function in Subjects With Acute Heart Failure Syndrome and Renal Impairment Who Are Hospitalized for Volume Overload and Require Intravenous Diuretic Therapy" @default.
- Q65387285 P2899 "+18" @default.
- Q65387285 P3098 "NCT00354458" @default.
- Q65387285 P31 Q30612 @default.
- Q65387285 P4844 Q7361410 @default.
- Q65387285 P580 "2006-10-01T00:00:00Z" @default.
- Q65387285 P582 "2009-07-01T00:00:00Z" @default.
- Q65387285 P6099 Q42824827 @default.
- Q65387285 P8363 Q78089383 @default.